Search research articles
Contact Us
Filters
Showing results (191-200 of 270) with videos related to
Page
of 27
Sort By:
BMC Medical Research Methodology
|
August 27, 2020
Rapid establishment of a COVID-19 perinatal biorepository: early lessons from the first 100 women enrolled
Lydia L Shook, Jessica E Shui, Adeline A Boatin, et al.
JCI Insight
|
September 9, 2025
Virologic characteristics of SARS-CoV-2 infection across evolving Omicron subvariants
Julie Boucau, Owen T Glover, Caitlin Marino, et al.
Mbio
|
August 3, 2023
Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern
Ryan P McNamara, Jenny S Maron, Julie Boucau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 23, 2022
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19)
Julie Boucau, Rockib Uddin, Caitlin Marino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Anne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
Genetic Epidemiology
|
June 23, 2021
Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain
Georg Hahn, Chloe M Wu, Sanghun Lee, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 4, 2022
Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical Trial
Kara W Chew, Carlee Moser, Eric S Daar, et al.
Annals of Internal Medicine
|
November 13, 2023
SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study
Gregory E Edelstein, Julie Boucau, Rockib Uddin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 10, 2023
SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy
Gregory E Edelstein, Julie Boucau, Rockib Uddin, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
COVID-19 induces persistent transcriptional changes in adipose tissue that are not associated with Long COVID
Soneida DeLine-Caballero, Kalani Ratnasiri, Heping Chen, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 270) with videos related to
Sort By:
Page
of 27
BMC Medical Research Methodology
|
August 27, 2020
Rapid establishment of a COVID-19 perinatal biorepository: early lessons from the first 100 women enrolled
Lydia L Shook, Jessica E Shui, Adeline A Boatin, et al.
JCI Insight
|
September 9, 2025
Virologic characteristics of SARS-CoV-2 infection across evolving Omicron subvariants
Julie Boucau, Owen T Glover, Caitlin Marino, et al.
Mbio
|
August 3, 2023
Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern
Ryan P McNamara, Jenny S Maron, Julie Boucau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 23, 2022
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19)
Julie Boucau, Rockib Uddin, Caitlin Marino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Anne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
Genetic Epidemiology
|
June 23, 2021
Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain
Georg Hahn, Chloe M Wu, Sanghun Lee, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 4, 2022
Bamlanivimab reduces nasopharyngeal SARS-CoV-2 RNA levels but not symptom duration in non-hospitalized adults with COVID-19: A Phase 2 Randomized Clinical Trial
Kara W Chew, Carlee Moser, Eric S Daar, et al.
Annals of Internal Medicine
|
November 13, 2023
SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy : An Observational Study
Gregory E Edelstein, Julie Boucau, Rockib Uddin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 10, 2023
SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy
Gregory E Edelstein, Julie Boucau, Rockib Uddin, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
COVID-19 induces persistent transcriptional changes in adipose tissue that are not associated with Long COVID
Soneida DeLine-Caballero, Kalani Ratnasiri, Heping Chen, et al.
Page
of 27